International Journal of Medical and Pharmaceutical Research
2025, Volume-6, Issue-2 doi: 10.5281/zenodo.15161696
Original Research Article
Risk-Benefit Assessment of Total Thyroidectomy versus Hemithyroidectomy in the Management of Benign Thyroid Nodules
Published
April 3, 2025
Abstract

Background: The optimal surgical approach for benign thyroid nodules remains controversial. This study aimed to compare the outcomes of total thyroidectomy versus hemithyroidectomy for benign thyroid nodules to inform clinical decision-making.

Methods: A prospective observational study was conducted on 70 patients (32 total thyroidectomy, 38 hemithyroidectomy) with benign thyroid nodules who underwent surgery between January and December 2024. Outcomes assessed included perioperative parameters, complications, functional outcomes, quality of life, and recurrence rates.

Results: The total thyroidectomy group had significantly larger nodules (3.8±1.2 vs. 3.2±0.9 cm, p=0.022) and higher prevalence of multinodular goiter (75.0% vs. 44.7%, p=0.011). Total thyroidectomy was associated with longer operative time (128.4±31.2 vs. 89.6±24.5 minutes, p<0.001), greater blood loss (78.5±36.2 vs. 52.3±28.7 mL, p=0.001), and extended hospital stay (3.2±0.9 vs. 2.1±0.8 days, p<0.001). Complication rates were significantly higher in the total thyroidectomy group (43.8% vs. 15.8%, p=0.009), primarily due to transient hypoparathyroidism (28.1% vs. 0%, p<0.001). All total thyroidectomy patients required levothyroxine compared to 18.4% in the hemithyroidectomy group (p<0.001). Quality of life assessment showed better overall scores in the hemithyroidectomy group (20.5±14.2 vs. 28.4±16.8, p=0.033). Among hemithyroidectomy patients, 18.4% developed new nodules and 5.3% required completion thyroidectomy within 12 months.

Conclusion: Hemithyroidectomy is associated with lower complication rates, reduced need for hormone replacement, and better quality of life compared to total thyroidectomy for benign thyroid nodules. However, these advantages must be balanced against the risk of recurrence and need for reoperation. The choice between procedures should be individualized based on patient characteristics, preferences, and risk profile.

Recommended Articles
Loading Image...
Volume-6, Issue-2
Citations
1568 Views
184 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved